Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30


Pre- and post-sexual exposure prophylaxis of HIV: An update.

Marfatia YS, Jose SK, Baxi RR, Shah RJ.

Indian J Sex Transm Dis. 2017 Jan-Jun;38(1):1-9. doi: 10.4103/ijstd.IJSTD_26_17. Review.


Risky sexual networks and concentrated HIV epidemics among men who have sex with men in Wenzhou, China: a respondent-driven sampling study.

Ma Q, Zeng S, Xia S, Pan X, Wang D, Zhu H, Wang H, Jiang T, He L, Zhao D, Peng Z.

BMC Public Health. 2015 Dec 16;15:1246. doi: 10.1186/s12889-015-2591-7.


Human beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cells.

Herrera R, Morris M, Rosbe K, Feng Z, Weinberg A, Tugizov S.

Virology. 2016 Jan;487:172-87. doi: 10.1016/j.virol.2015.09.025. Epub 2015 Nov 2.


Exposure to pornographic videos and its effect on HIV-related sexual risk behaviours among male migrant workers in southern India.

Mahapatra B, Saggurti N.

PLoS One. 2014 Nov 25;9(11):e113599. doi: 10.1371/journal.pone.0113599. eCollection 2014.


Current perspectives in HIV post-exposure prophylaxis.

Sultan B, Benn P, Waters L.

HIV AIDS (Auckl). 2014 Oct 24;6:147-58. doi: 10.2147/HIV.S46585. eCollection 2014. Review.


Oral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected.

Kohli A, Islam A, Moyes DL, Murciano C, Shen C, Challacombe SJ, Naglik JR.

PLoS One. 2014 May 23;9(5):e98077. doi: 10.1371/journal.pone.0098077. eCollection 2014.


Comparison of the immune microenvironment of the oral cavity and cervix in healthy women.

Fakhry C, Marks MA, Gilman RH, Cabrerra L, Yori P, Kosek M, Gravitt PE.

Cytokine. 2013 Nov;64(2):597-604. doi: 10.1016/j.cyto.2013.08.009. Epub 2013 Sep 7.


The characteristics of heterosexual STD clinic attendees who practice oral sex in Zhejiang Province, China.

Ma Q, Pan X, Cai G, Yan J, Xu Y, Ono-Kihara M, Kihara M.

PLoS One. 2013 Jun 25;8(6):e67092. doi: 10.1371/journal.pone.0067092. Print 2013.


Differential innate immune responses to low or high dose oral SIV challenge in Rhesus macaques.

Durudas A, Chen HL, Gasper MA, Sundaravaradan V, Milush JM, Silvestri G, Johnson W, Giavedoni LD, Sodora DL.

Curr HIV Res. 2011 Jul;9(5):276-88.


Concentrations of tenofovir and emtricitabine in saliva: implications for preexposure prophylaxis of oral HIV acquisition.

de Lastours V, Fonsart J, Burlacu R, Gourmel B, Molina JM.

Antimicrob Agents Chemother. 2011 Oct;55(10):4905-7. doi: 10.1128/AAC.00120-11. Epub 2011 Jul 25.


Characterization of SIV in the oral cavity and in vitro inhibition of SIV by rhesus macaque saliva.

Thomas JS, Lacour N, Kozlowski PA, Nelson S, Bagby GJ, Amedee AM.

AIDS Res Hum Retroviruses. 2010 Aug;26(8):901-11. doi: 10.1089/aid.2009.0235.


Oral sex, oral health and orogenital infections.

Saini R, Saini S, Sharma S.

J Glob Infect Dis. 2010 Jan;2(1):57-62. doi: 10.4103/0974-777X.59252.


Elevated levels of innate immune modulators in lymph nodes and blood are associated with more-rapid disease progression in simian immunodeficiency virus-infected monkeys.

Durudas A, Milush JM, Chen HL, Engram JC, Silvestri G, Sodora DL.

J Virol. 2009 Dec;83(23):12229-40. doi: 10.1128/JVI.01311-09. Epub 2009 Sep 16.


Oral complications of HIV disease.

Leao JC, Ribeiro CM, Carvalho AA, Frezzini C, Porter S.

Clinics (Sao Paulo). 2009 May;64(5):459-70. Review.


Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals.

Zapata W, Rodriguez B, Weber J, Estrada H, QuiƱones-Mateu ME, Zimermman PA, Lederman MM, Rugeles MT.

Curr HIV Res. 2008 Nov;6(6):531-8.


Systematic review of orogenital HIV-1 transmission probabilities.

Baggaley RF, White RG, Boily MC.

Int J Epidemiol. 2008 Dec;37(6):1255-65. doi: 10.1093/ije/dyn151. Epub 2008 Jul 29. Review.


Clinic-based intervention reduces unprotected sexual behavior among HIV-infected patients in KwaZulu-Natal, South Africa: results of a pilot study.

Cornman DH, Kiene SM, Christie S, Fisher WA, Shuper PA, Pillay S, Friedland GH, Thomas CM, Lodge L, Fisher JD.

J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):553-60. doi: 10.1097/QAI.0b013e31817bebd7.


Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.

Kazmi SH, Naglik JR, Sweet SP, Evans RW, O'Shea S, Banatvala JE, Challacombe SJ.

Clin Vaccine Immunol. 2006 Oct;13(10):1111-8. Epub 2006 Aug 23.

Supplemental Content

Support Center